Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)

Sponsor
Memorial Sloan Kettering Cancer Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05770570
Collaborator
(none)
1,067
1
3
43.6
24.5

Study Details

Study Description

Brief Summary

The researchers will conduct 'Taxi ROADmAP (Realizing Optimization Around Diet And Physical activity)', which also utilizes MOST, and the same 4 obesity intervention components as in SANOS, but targets the overweight/obesity crisis in another at-risk, low socioeconomic status (SES) population, taxi and for-hire vehicle (FHV) drivers (Lyft, Uber, etc.). ROADMAP also utilizes an effectiveness- implementation hybrid type 1 design. Hybrid trials, which blend effectiveness and implementation studies, can lead to more rapid translational uptake and more effective implementation. Taxi and FHV drivers are a growing, multilingual, hard-to-reach, predominantly immigrant and minority essential worker population. There are over 750,000 licensed taxi and FHV drivers in in the U.S. and over 185,000 in New York City (NYC). They have higher rates of overweight/obese range body mass index (BMI) than New Yorkers in general (77% vs 56%) and have high rates of elevated waist circumference, sedentary behavior, poor diets, and health care services underutilization. ROADmAP will test 4 evidence- and theory-based (Social Cognitive Theory [SCT]) behavior change intervention components. We will use MOST to identify which of the 4 components contribute most significantly and cost-effectively to weight loss among NYC drivers recruited at workplace health fairs (HFs) and virtually. Objectives are to apply MOST to design an optimized version of a scalable, lifestyle intervention for taxi/FHV drivers, and then to conduct a mixed methods multistakeholder process evaluation to facilitate widespread intervention implementation.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Counseling
  • Behavioral: Text Messages
  • Behavioral: Phone calls
  • Behavioral: Self-monitoring tools
Phase 2

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1067 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
Actual Study Start Date :
Dec 22, 2022
Anticipated Primary Completion Date :
Jan 11, 2026
Anticipated Study Completion Date :
Aug 11, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: ROADmAP schema

Participants will be randomly assigned to one of eight study groups which will be one or a combination of 4 conditions: (1) in person individualized diet and exercise counseling (2) diet and exercise text messages (3) weekly telephone support and (4) self-monitoring tools for diet and weight. For the first part of the study, Survey, approximately 64 drivers and 36 management staff will take pate in the feedback questionnaire. For the second part of the study, Interview, approximately 8 drivers and 12 management staff may be invited to take part in an interview via phone, in person, or teleconference (Zoom).

Behavioral: Counseling
In-person individual diet and physical activity (PA) counseling

Behavioral: Text Messages
Thrice-weekly diet/physical activity(PA) text messages

Behavioral: Phone calls
Weekly telephone support

Behavioral: Self-monitoring tools
Self-monitoring tools

Other: Consumo de Opciones Mas Ideales De Alimento (COMIDA)

Participants will be placed in either individual or group interventions by convenience. Recruitment will be consecutive and participants will be placed in either intervention depending on what resource is available on a given day at the VDS, individual counselor or a group educator.

Behavioral: Phone calls
Weekly telephone support

Other: SANOS

Conducting SANOS Focus Groups. We will conduct 3-5 focus groups (in Spanish) with 6-10 participants each, until saturation. Bilingual study staff will approach individuals visiting the VDS and VDS Mobile for potential participation. A brief screening questionnaire will be administered, and a BMI assessment conducted, to ascertain eligibility. Focus groups will be scheduled at the VDS Mobile unit at times convenient to participants. Participants will be verbally consented in Spanish, and will be apprised that their participation is purely voluntary and that their names will not be included in the final narrative. The 6-month follow-up and my plate dietary surveys can be done over phone. Study staff will access step counts (or obtain it through phone via the pedometer manual provided to the participant) and upload data onto the REDCap tracking tool. Staff may ask participants to report step counts captured by their personal devices (i.e., phone or smartwatch).

Behavioral: Self-monitoring tools
Self-monitoring tools

Outcome Measures

Primary Outcome Measures

  1. Difference in participant body weight from baseline to 12 months [12-months post-intake]

    Efficacy of intervention is achieved when participants have weight loss with a minimum threshold of 5% of overall body weight lost Intervention components include: Initial in-person individual diet and physical activity (PA) counseling Thrice-weekly diet/PA text messages Weekly telephone support Self-monitoring tools.

  2. Estimate the cost and incremental cost-effectiveness of the obesity intervention components [Up to 6 months]

    Costs associated with each component include: 1) In-person counseling: personnel time, participant travel time, text messaging services; 3) Telephone support: personnel time; 4) Self-monitoring tools: food diaries and digital scales.

  3. Feasibility of weight loss intervention for participants measured by the ROAmAP Process Evaluation Questionnaire [Up to 12 months]

    The ROADmAP Process Evaluation Questionnaire will be administered to all participants to gather data on implementation potential. Questions are on a Likert scale and will collect intervention delivery facilitators and barriers, intervention sustainability facilitators and barriers post-study completion. Feasibility will be indicated by extreme Likert scores (Strongly Agree, Neutral, Strongly Disagree).

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
For COMIDA participants only:
  • Self-Identifies as Mexican American or Mexican

  • Seeking services at the VDS of the Mexican Consulate

  • Prefers to speak in Spanish

  • All adults at least 18 years of age

  • Screens as obese (an adult who has a Body Mass Index (BMI) 30 or higher) or overweight (an adult who has a BMI between 25 - 29.9)

  • Agrees to be audio recorded

For SANOS focus group participants only:
  • Self-identifies as Hispanic/Latino;

  • Seeking services at VDS or VDS Mobile;

  • Prefers to speak in Spanish;

  • At least 18 years of age;

  • Screens as obese (BMI ≥ 30 kg/m2) or overweight (BMI of 25 - 29.9 kg/m2);

  • Agrees to be audio recorded

For SANOS RCT participants only:
  • Self-identifies as Hispanic/Latino;

  • Seeking services at VDS or VDS Mobile;

  • Prefers to speak in Spanish;

  • At least 18 years of age;

  • Screens as obese (BMI ≥ 30 kg/m2) or overweight (BMI of 25 - 29.9 kg/m2);

  • Owns a cell phone capable of receiving text messages;

  • Agrees to be audio recorded

For Family COMIDA participants only:
  • Self-Identifies as Hispanic/Latino

  • Seeking services at the VDS (or has used VDS services in the past) of the Mexican - Consulate or VDS Mobile

  • Prefers to speak in Spanish

  • At least 18 years of age

  • Has at least one child under age 18 living in the same household

  • Owns a cell phone capable of receiving text messages

  • Willing to receive text messages (3 texts per week for 3 months)

  • Owns an internet connected device (eg, cell phone, tablet, etc) capable of conducting teleconference calls (eg, Zoom)

For ROADmAP RCT participants only:
  • At least 21 years of age

  • Full-time (drives at least 35 hours per week) licensed taxi/FHV driver

  • Driver for at least 6 months

  • Seeking Health Fairs (or has used Health Fairs services in the past)

  • Speaks English, French, Bengali, or Spanish

  • Screens a as obese (BMI ≥ 30 kg/m2 [≥25 kg/m2 for South Asians]) or overweight (BMI of 25 - 29.9 kg/m2 s [23- 24.9 kg/m2 for South Asians])

  • (BMI cut-offs are lower for South Asians, per WHO and American Diabetes Association recommendations)

  • Owns a cell phone capable of receiving text messages

  • Agrees to be audio-recorded

For ROADmAP Phase 2 participants only:
  • At least 21 years of age

  • Driver who participated in ROADmAP RCT or manager at a taxi garage, Uber, Lyft or driver serving/union/organization

  • Agrees to be audio-recorded

Exclusion Criteria:
For COMIDA participants only:
  • Will not be in the NYC area for the study duration (3-4 months) Is pregnant or might be pregnant

  • Lactating women

  • Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (Individuals with diabetes, lactose intolerance, and high blood pressure MAY still participate in the study)

  • Has dietary restrictions (i.e. liquid diet)

  • Does not have a phone that accepts text messages or unwilling to accept text messages

  • Presence of a serious psychiatric or cognitive impairment likely to preclude meaningful informed consent and adherence to the protocol per the consenting professional"s judgment

  • Has another family member already enrolled in COMIDA (as determined by patient report)

For SANOS focus group participants only:
  • Is pregnant or might be pregnant; lactating women;

  • Self-reported presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with HTN and DM may still participate);

  • Has dietary restrictions (i.e. liquid diet);

  • Has a household member who has already participated (or agreed to participate);

For SANOS RCT participants only:
  • Is pregnant or might be pregnant; lactating women; for the study duration (6 months)

  • Self-reported presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with HTN and DM may still participate); restricting diet;

  • Currently has dietary restrictions (i.e. liquid diet);

  • Has a household member who has already participated (or agreed to participate);

  • Has already participated in the study

  • Will not be in the NY Metropolitan area for the study duration (6 months) Works for or with the Mexican consulate (including employment and/or collaborative or volunteer services)

For Family COMIDA participants only:
  • Is pregnant or might be pregnant; lactating women for the study duration (3 months)

  • Will not be in the NY Metropolitan area for the study duration (3 months) Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (Individuals with diabetes, lactose intolerance, and high blood pressure MAY still participate in the study)

  • Has dietary restrictions (i.e. liquid diet)

  • Has another family member who has already participated in COMIDA or SANOS

  • Has already participated in the study

  • Works for or with the Mexican consulate (including employment and/or collaborative or volunteer services)

For ROADmAP RCT participants only:
  • Is pregnant or might be pregnant; lactating women; for the study duration (12 months)

  • Self-reported presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with HTN and DM may still participate) that may restrict diet

  • Currently has dietary restrictions (i.e. liquid diet)

  • Has a household member who has already participated (or agreed to participate)

  • Has already participated in the study

  • Will not be in the NY Metropolitan area for 6 months from study enrollment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mexican Consulate's Ventanilla de Salud (VDS) New York New York United States 10016

Sponsors and Collaborators

  • Memorial Sloan Kettering Cancer Center

Investigators

  • Principal Investigator: Jennifer Leng, MD, MPH, Memorial Sloan Kettering Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT05770570
Other Study ID Numbers:
  • 15-088A(27)
First Posted:
Mar 15, 2023
Last Update Posted:
Mar 22, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Memorial Sloan Kettering Cancer Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 22, 2023